SG11201402226PA - Therapeutic agent for arthrosis - Google Patents
Therapeutic agent for arthrosisInfo
- Publication number
- SG11201402226PA SG11201402226PA SG11201402226PA SG11201402226PA SG11201402226PA SG 11201402226P A SG11201402226P A SG 11201402226PA SG 11201402226P A SG11201402226P A SG 11201402226PA SG 11201402226P A SG11201402226P A SG 11201402226PA SG 11201402226P A SG11201402226P A SG 11201402226PA
- Authority
- SG
- Singapore
- Prior art keywords
- arthrosis
- therapeutic agent
- therapeutic
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011247047 | 2011-11-11 | ||
| PCT/JP2012/076478 WO2013069404A1 (en) | 2011-11-11 | 2012-10-12 | Therapeutic agent for joint diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201402226PA true SG11201402226PA (en) | 2014-10-30 |
Family
ID=48289788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201402226PA SG11201402226PA (en) | 2011-11-11 | 2012-10-12 | Therapeutic agent for arthrosis |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9085593B2 (en) |
| EP (1) | EP2803359B1 (en) |
| JP (1) | JP5465815B2 (en) |
| KR (1) | KR101953181B1 (en) |
| CN (1) | CN103906519B (en) |
| AU (1) | AU2012337087B2 (en) |
| BR (1) | BR112014011315B8 (en) |
| CA (1) | CA2855660C (en) |
| ES (1) | ES2634008T3 (en) |
| HK (1) | HK1199406A1 (en) |
| IN (1) | IN2014CN04222A (en) |
| MY (1) | MY168931A (en) |
| RU (1) | RU2646457C2 (en) |
| SG (1) | SG11201402226PA (en) |
| WO (1) | WO2013069404A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3483169B1 (en) * | 2014-08-12 | 2021-05-26 | Otsuka Chemical Co., Ltd. | Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same |
| JPWO2022114058A1 (en) | 2020-11-26 | 2022-06-02 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2700350B2 (en) | 1990-04-20 | 1998-01-21 | 小糸工業株式会社 | Vehicle detector |
| JP3195833B2 (en) | 1991-09-30 | 2001-08-06 | きみ子 室伏 | New physiologically active substance and method for producing the same |
| JPH07149772A (en) * | 1993-11-26 | 1995-06-13 | Sagami Chem Res Center | Activity promoter of protein phosphorylated enzyme c |
| JPH07258278A (en) | 1994-03-18 | 1995-10-09 | Sagami Chem Res Center | Dna polymerase alpha inhibitor containing 1-o-acylglycerol-2,3-phosphate derivative as active ingredient |
| JPH0925235A (en) | 1995-07-13 | 1997-01-28 | Sagami Chem Res Center | Suppressant for cancer metastasis containing 1-o-acylglycerol 2,3-phosphate derivative as active ingredient |
| JP2001178489A (en) | 1999-12-24 | 2001-07-03 | Kimiko Murofushi | Method of producing cyclic phosphatidic acid |
| JP4815063B2 (en) * | 2001-04-13 | 2011-11-16 | きみ子 室伏 | Drugs for promoting the proliferation, differentiation and / or survival of glial cells containing cyclic phosphatidic acid |
| JP4836345B2 (en) * | 2001-04-13 | 2011-12-14 | きみ子 室伏 | Neuronal survival promoter containing cyclic phosphatidic acid derivative |
| JP4163007B2 (en) * | 2001-05-21 | 2008-10-08 | きみ子 室伏 | Cancer metastasis inhibitor containing carbacyclic phosphatidic acid derivative |
| JP4162927B2 (en) * | 2002-06-11 | 2008-10-08 | きみ子 室伏 | Carbacyclic phosphatidic acid derivatives |
| RU2240131C1 (en) * | 2003-04-04 | 2004-11-20 | Аладьев Сергей Иванович | Agent "artrovit" for prophylaxis and treatment of arthritis and arthrosis |
| US20040204383A1 (en) * | 2003-04-11 | 2004-10-14 | Gabor Tigyi | Lysophosphatidic acid analogs and inhibition of neointima formation |
| BRPI0607385A2 (en) | 2005-02-16 | 2009-09-01 | Schering Corp | heterocyclic substituted piperazine with cxcr3 antagonist activity |
| JP5077893B2 (en) * | 2006-12-28 | 2012-11-21 | 国立大学法人お茶の水女子大学 | Analgesics containing cyclic phosphatidic acid derivatives |
| JP2010189315A (en) | 2009-02-18 | 2010-09-02 | Unitika Ltd | Healing accelerator for articular cartilage lesion and food and drink containing the same |
-
2012
- 2012-10-12 EP EP12847890.6A patent/EP2803359B1/en active Active
- 2012-10-12 ES ES12847890.6T patent/ES2634008T3/en active Active
- 2012-10-12 JP JP2013542900A patent/JP5465815B2/en active Active
- 2012-10-12 CN CN201280055135.7A patent/CN103906519B/en active Active
- 2012-10-12 AU AU2012337087A patent/AU2012337087B2/en active Active
- 2012-10-12 US US14/357,089 patent/US9085593B2/en active Active
- 2012-10-12 KR KR1020147015608A patent/KR101953181B1/en active IP Right Grant
- 2012-10-12 CA CA2855660A patent/CA2855660C/en active Active
- 2012-10-12 WO PCT/JP2012/076478 patent/WO2013069404A1/en active Application Filing
- 2012-10-12 BR BR112014011315A patent/BR112014011315B8/en active IP Right Grant
- 2012-10-12 MY MYPI2014701211A patent/MY168931A/en unknown
- 2012-10-12 SG SG11201402226PA patent/SG11201402226PA/en unknown
- 2012-10-12 RU RU2014123690A patent/RU2646457C2/en active
- 2012-10-12 IN IN4222CHN2014 patent/IN2014CN04222A/en unknown
-
2014
- 2014-12-29 HK HK14113014.9A patent/HK1199406A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2803359A1 (en) | 2014-11-19 |
| CN103906519A (en) | 2014-07-02 |
| HK1199406A1 (en) | 2015-07-03 |
| RU2014123690A (en) | 2015-12-20 |
| NZ624870A (en) | 2016-01-29 |
| US9085593B2 (en) | 2015-07-21 |
| BR112014011315A2 (en) | 2017-05-09 |
| CA2855660A1 (en) | 2013-05-16 |
| AU2012337087A1 (en) | 2014-06-05 |
| US20140309194A1 (en) | 2014-10-16 |
| JPWO2013069404A1 (en) | 2015-04-02 |
| ES2634008T3 (en) | 2017-09-26 |
| BR112014011315B1 (en) | 2020-03-03 |
| KR20140098778A (en) | 2014-08-08 |
| BR112014011315B8 (en) | 2020-09-15 |
| IN2014CN04222A (en) | 2015-07-17 |
| EP2803359B1 (en) | 2017-04-19 |
| JP5465815B2 (en) | 2014-04-09 |
| CA2855660C (en) | 2019-04-16 |
| EP2803359A4 (en) | 2015-12-16 |
| WO2013069404A1 (en) | 2013-05-16 |
| KR101953181B1 (en) | 2019-02-28 |
| RU2646457C2 (en) | 2018-03-05 |
| CN103906519B (en) | 2017-10-10 |
| MY168931A (en) | 2019-01-09 |
| AU2012337087B2 (en) | 2016-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2673286A4 (en) | Therapeutic compounds | |
| ZA201305897B (en) | Combination therapy | |
| GB201114212D0 (en) | Therapeutic agents | |
| GB201212513D0 (en) | Therapeutic agents | |
| EP2666475A4 (en) | Therapeutic agent for alopecia | |
| ZA201400120B (en) | Combination therapy | |
| GB201119401D0 (en) | Therapeutic agents | |
| EP2740420A4 (en) | Therapeutic implement | |
| IL227558A0 (en) | Therapeutic agent for tumor | |
| EP2790628A4 (en) | Diaper | |
| EP2767257A4 (en) | Articulator | |
| ZA201502595B (en) | Therapeutic methods | |
| GB201217704D0 (en) | Therapeutic agents | |
| PL2723330T3 (en) | Vasoconstrictor-containing agent for combination therapy | |
| GB2525835B (en) | Pharmaceutical agent | |
| EP2701744A4 (en) | Combination therapy | |
| EP2750508A4 (en) | Therapeutic compounds and methods | |
| EP2688566A4 (en) | Anticancer therapeutic agents | |
| ZA201308176B (en) | Therapeutic treatment | |
| HK1174525A1 (en) | Articulator | |
| EP2687212A4 (en) | Medicament | |
| SG11201402226PA (en) | Therapeutic agent for arthrosis | |
| GB201206306D0 (en) | Therapeutic apparatus | |
| GB201102913D0 (en) | Novel therapeutic | |
| GB201115558D0 (en) | Therapeutic agents |